Analysts/Institutional Investor Meet/Con. Call Updates

01 September 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block - G Dalal Street Bandra-Kurla Complex Mumbai – 400001 Bandra (East), Mumbai - 400051 Scrip Code: 524404 Symbol: MARKSANS Sub: Intimation of Schedule of the Investors/Analysts Meet Dear Sir/Madam, This is to inform you that pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma Limited (“the Company”) will participate in the below scheduled investor/analysts meet. Sr. No. Particulars of Meet Date & Time of Meeting Type of Meet Location / Mode of Meeting 1 Ashwamedh - Elara 02nd September, 2026 Group Meet Hyatt, Santacruz East, India Dialogue 2026 Mumbai/ Physical Further, no unpublished price sensitive information pertaining to the Company will be shared during the meet with Analysts/Investors. Please note that the above may subject to change due to exigencies on the part of Investors/analysts or the Company. A copy of this disclosure is being updated on website of the Company at www.marksanspharma.com This is for your information and records. Yours faithfully For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com